Sebelipase alfa
Sebelipase alfa is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including KANUMA. Available dosage form: injection, solution, concentrate.
Drug Details
- Generic Name
- Sebelipase alfa
- Brand Names
- KANUMA
- Application Number
- BLA125561
- Sponsor
- Alexion Pharmaceuticals, Inc.
- NDC Codes
- 1
- Dosage Forms
- INJECTION, SOLUTION, CONCENTRATE
- Routes
- INTRAVENOUS
- Active Ingredients
- SEBELIPASE ALFA
Indications and Usage
1 INDICATIONS AND USAGE KANUMA ® is indicated for the treatment of patients with a diagnosis of Lysosomal Acid Lipase (LAL) deficiency. KANUMA ® is a hydrolytic lysosomal cholesteryl ester and triacylglycerol-specific enzyme indicated for the treatment of patients with a diagnosis of Lysosomal Acid Lipase (LAL) deficiency. ( 1 )